Posted in
Cardiovascular,
Disease & Disorders No discussion yet on February 8th, 2010
A study conducted by researchers from the Mayo Clinic reveals that those patients who took heart medications were risking potential grave reactions when they additionally consumed herbal remedies like St. John’s wort, garlic, ginkgo biloba among several others.
Researchers spotted several alternative, herbal remedies which must not be taken by heart patients on drugs for treating cardiac ailments.
They claimed that these herbal remedies could be problem-causing when consumed with medicine prescriptions for lowering blood pressure, controlling cholesterol, stabilizing irregular cardiovascular rhythms or preventing blood clot formations.
Investigators pointed out that heart patients mostly do not keep their physicians informed about any herbal or alternative products they were taking as they fail to identify the likely harm that these remedies could cause. For such individuals natural synonymously translated to being risk-free. Though these medications have been used for hundreds of [...]
Posted in
Cardiovascular,
Disease & Disorders No discussion yet on January 29th, 2010
Scientists from MIT and Harvard have designed novel nanoburr particles having small protein pieces that could adhere to damage-ridden arterial walls, eventually releasing the medicine like paclitaxel that stalls cell division and assists in preventing scar tissue development which could lead to clogging up of arteries. Nanoburrs are fascinating exemplars of nanotechnology wherein nanoparticles could have targeted action on injured vascular tissues. Presently, one of the benchmark means of treating arteries having clogging and damage is vascular stent implantation that keeps the artery open and gradually releases medicines like paclitaxel. The investigators are hopeful that their new-fangled nanoburrs could be employed together with these stents – or instead of them – for treating damage situated in regions unsuited for stents like those close to a junction in the artery. Interior of the sixty nanometer broadness particles carry the medicine that is bounded to a polymer chain known as [...]
Posted in
Cardiovascular,
Disease & Disorders No discussion yet on January 22nd, 2010
The Food and Drug Administration (FDA) has stated that Vytorin as safe, although the statin Zocor is believed to has comparatively better functionality and at lesser cost. Just last year, FDA raised doubts due to the recently done trial outcomes on Vytorin that has made it query the largely acknowledged notion that lowering LDL cholesterol levels reduces the risk of heart attacks and strokes. Especially bothersome were the observation of greater number of Vytorin users from the studies facing fatalities due to such occurrences as compared to Zocor (statin drug) users.
The FDA has revised its safety reassessment of cholesterol-lessening medications and reiterated its stance that elevated LDL levels is a heart risk factor hence reducing it is considered optimal for health.
The beginning of last year, physicians were flooded with calls from apprehensive Vytorin users (a single tablet combo having Zocor plus non-statin Zetia). A seven hundred plus entrant study at large by Vytorin’s United [...]